|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 622 DKK | +3.84% |
|
+6.60% | +66.67% |
| Apr. 04 | U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year | DJ |
| Mar. 20 | Zealand Pharma A/S Approves Appointments to the Board | CI |
Zealand Pharma A/S reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was DKK 342.79 million compared to DKK 103.99 million a year ago. Net loss was DKK 703.74 million compared to DKK 1,202.14 million a year ago.
Basic loss per share from continuing operations was DKK 12.44 compared to DKK 20.9 a year ago. Basic loss per share was DKK 12.44 compared to DKK 26.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +66.67% | 5.55B | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ZEALAND PHARMA A/S 
